NFKB1 and early-onset autosomal dominant Alzheimer disease: Resveratrol is proven to suppress the expression of pro-inflammatory molecules such as NF-kB and TNF-α in glial cells, while also increasing the amount of the anti-inflammatory cytokine IL-10, which is linked to Alzheimer’s diseases.